- Home
- ROIV vs LW Comparison
ROIV vs LW Comparison
Compare ROIV & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- LW
- Stock Information
- Founded
- ROIV 2014
- LW 1950
- Country
- ROIV United Kingdom
- LW United States
- Employees
- ROIV N/A
- LW N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- LW Packaged Foods
- Sector
- ROIV Health Care
- LW Consumer Staples
- Exchange
- ROIV Nasdaq
- LW Nasdaq
- Market Cap
- ROIV 8.4B
- LW 7.3B
- IPO Year
- ROIV N/A
- LW N/A
- Fundamental
- Price
- ROIV $10.67
- LW $51.37
- Analyst Decision
- ROIV Buy
- LW Buy
- Analyst Count
- ROIV 4
- LW 12
- Target Price
- ROIV $17.50
- LW $71.08
- AVG Volume (30 Days)
- ROIV 5.9M
- LW 1.5M
- Earning Date
- ROIV 05-29-2025
- LW 04-03-2025
- Dividend Yield
- ROIV N/A
- LW 2.88%
- EPS Growth
- ROIV N/A
- LW N/A
- EPS
- ROIV N/A
- LW 2.55
- Revenue
- ROIV $122,585,000.00
- LW $6,387,400,000.00
- Revenue This Year
- ROIV N/A
- LW $1.32
- Revenue Next Year
- ROIV N/A
- LW $1.19
- P/E Ratio
- ROIV N/A
- LW $20.15
- Revenue Growth
- ROIV 140.04
- LW N/A
- 52 Week Low
- ROIV $8.73
- LW $47.90
- 52 Week High
- ROIV $13.06
- LW $89.51
- Technical
- Relative Strength Index (RSI)
- ROIV 47.82
- LW 44.45
- Support Level
- ROIV $10.58
- LW $50.38
- Resistance Level
- ROIV $11.77
- LW $52.45
- Average True Range (ATR)
- ROIV 0.34
- LW 1.23
- MACD
- ROIV -0.07
- LW -0.01
- Stochastic Oscillator
- ROIV 7.56
- LW 39.04
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About LW Lamb Weston Holdings Inc.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 14% of fiscal 2024 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.